None
Quote | Oncolytics Biotech Inc. (NASDAQ:ONCY)
Last: | $0.99 |
---|---|
Change Percent: | 0.52% |
Open: | $0.99 |
Close: | $0.99 |
High: | $1.01 |
Low: | $0.99 |
Volume: | 180,693 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Oncolytics Biotech Inc. (NASDAQ:ONCY)
Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program Canada NewsWire Clear path forward on key elements of the planned potential registration-enabling trial in HR+/HER2- metastatic breast cancer On track to report ove...
Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence Canada NewsWire Wayne Pisano , Chair of Oncolytics' Board of Directors, to serve as interim CEO Overall Survival data from BRACELET-1 breast ca...
Message Board Posts | Oncolytics Biotech Inc. (NASDAQ:ONCY)
Subject | By | Source | When |
---|---|---|---|
Next stop $3.00 then $4.00 then its pretty | accipiterr | investorshub | 06/22/2023 3:45:38 PM |
Also Phase 1 Clinical trials for viral loaded | accipiterr | investorshub | 06/22/2023 3:24:46 PM |
$ONCY IS A PHASE 3 BIOTECH COMPANY WITH | accipiterr | investorshub | 06/22/2023 3:20:16 PM |
I am here. Here is a comment for | accipiterr | investorshub | 06/22/2023 3:08:51 PM |
NEWS -- Oncolytics Biotech's® Pelareorep Selected for Inclusion | Paulness | investorshub | 06/22/2023 1:39:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Oncolytics Biotech Inc. Company Name:
ONCY Stock Symbol:
NASDAQ Market:
Oncolytics Biotech Inc. Website:
Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program Canada NewsWire Clear path forward on key elements of the planned potential registration-enabling trial in HR+/HER2- metastatic breast cancer On track to report ove...
Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence Canada NewsWire Wayne Pisano , Chair of Oncolytics' Board of Directors, to serve as interim CEO Overall Survival data from BRACELET-1 breast ca...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...